We are pleased to introduce you to TargetCancer Foundation's newest volunteer, Giselle Mota. Originally from Los Angeles, CA, Giselle currently resides in...
Introducing Giselle Mota, our Newest Volunteer!
read more
OnTarget
A Rare Cancer Blog
Meet TCF Volunteer Cami Harris
Originally from Greensboro, NC, Cami Herring currently lives in Cambridge, MA with her chihuahua, Coco. Cami is a Project Analyst at Mintz working with the...
Introducing TCF Volunteer Catherine May
Originally from Dalton, MA, Catherine moved to the Boston area in 2020 after graduating from Williams College. She is a Senior Practice Coordinator at Mintz....
2022 Gala Volunteer Spotlight
As the 2022 TargetCancer Foundation Gala approaches, we are pleased to feature some of our wonderful volunteers, whose efforts are integral to the Gala's...
Honoring Our Past, Celebrating Our Progress: FDA Approves Tibsovo for Cholangiocarcinoma with IDH1 Mutation
Just a few days ago, we sent a remembrance of our founder, Paul Poth. It seems especially meaningful today to send along news of a different type- the very...
Promising New Cholangiocarcinoma Treatment Findings
An exciting paper was recently published in Cancer Discovery highlighting the promise of the recently FDA approved FGFR inhibitor drugs for an even broader...
Importance of Local Physicians at the TRACK Virtual Molecular Tumor Board
The rapid progress made over the last decade in bringing comprehensive genomic profiling to rare cancer patients has created the opportunity to significantly...
TRACK (Target Rare Cancer Knowledge) Virtual Molecular Tumor Board
The TRACK Study incorporates many features that make it unique and especially significant for rare cancer patients. One of these features is the Virtual...
Grief – You’re Back Again?
Written by Kristen Palma, TargetCancer Foundation President. Here is what I have learned about grief after having to cope with it for eleven years. It is...
Rare Cancer Research During COVID-19
By TCF research grant recipients Nabeel Bardeesy, PhD, of the Massachusetts General Hospital Cancer Center, and Adam Bass, MD of Dana-Farber Cancer...
My Story of Grief: Experiencing the loss of a loved one during COVID-19
By Kimberley Balkus, TCF volunteer and advocate 2,403 days. The number of days that my mom, Geri Keegan, lived with cholangiocarcinoma. She was given one year...
Breaking New Ground: FDA Approves Pemazyre, the First Targeted Therapy for Cholangiocarcinoma
In the midst of such a challenging time, I wanted to take a moment to share some very positive and exciting news with you. Late last week, the FDA granted...
In Julienne’s Footsteps: Climbing Mt. Kilimanjaro to Honor a Life
By guest writer Karen Dempsey The bonds that Julienne Morriss Callaway forged and the values she embraced in life have been instrumental in sustaining her...
An Insider’s Perspective
Dr. Monika Laszkowska, a gastroenterology fellow, next to the poster she presented at the 2019 TargetCancer Foundation Think Tank on Advancing...
2019 Cholangiocarcinoma Research Grant Announcement
TargetCancer Foundation is proud to announce a new two-year, $240,000 grant to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center brings our...